MedTrace Logo

Burden of Herpes Zoster and Post-herpetic Neuralgia Among People ≥ 50 Years Old in France

NCT02487472 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2019-09-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the burden of Herpes zoster (HZ) and post-herpetic neuralgia (PHN) among people ≥ 50 years old in France, in terms of healthcare resources used, medical direct and indirect costs, as well as pain severity and impact on quality of life.

Conditions

  • Herpes Zoster

Interventions

OTHER

Data collection

Data sheet, ZBPI questionnaire and EQ-5D 5L Health state questionnaire

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-19
Primary Completion
2017-08-28
Completion
2017-08-28

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02487472 on ClinicalTrials.gov